ZEB2 Antibody [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-77179F
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
ELISA, Immunocytochemistry/ Immunofluorescence, Western Blot
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Antibody was raised against an 18 amino acid synthetic peptide near the carboxy terminus of human ZEB2. The immunogen is located within the last 50 amino acids of ZEB2. Amino Acid Squence: DDSSEDGKMETKSDHEED
Reactivity Notes
0
Specificity
ZEB2 antibody is predicted to not cross-react with ZEB1.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for ZEB2 Antibody [FITC]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Peptide affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: ZEB2/SIP1
Alternate Names
HSPC082, SIP1, SMADIP1, ZFHX1B
Gene Symbol
ZEB2
Additional ZEB2/SIP1 Products
Product Documents for ZEB2 Antibody [FITC]
Product Specific Notices for ZEB2 Antibody [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...